Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the phate tm model

Integrated Environmental Assessment and Management

Volumn 8, Issue 3, 2012, Pages 530-542

  Cunningham, Virginia L ^a   D'aco, Vincent J ^b   Pfeiffer, Danielle ^c   Anderson, Paul D ^d   Buzby, Mary E ^e   Jahnke, James ^e   Hannah, Robert E ^f   Parke, Neil J ^g  

^a Sustainability Sciences LLC   (United States)

^b Quantum Management Group Inc   (United States)

^c ARCADIS US   (United States)

^d Arcadis US   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f GLAXOSMITHKLINE   (United States)

^g ELI LILLY AND COMPANY   (United States)

Author keywords

Biosolids phate tm; Pharmaceutical model

Indexed keywords

DRUG RESIDUE; ORGANIC COMPOUND;

ARTICLE; CHEMISTRY; CITY; ENVIRONMENT; HUMAN; SEWAGE; THEORETICAL MODEL;

CITIES; DRUG RESIDUES; ENVIRONMENT; HUMANS; MODELS, THEORETICAL; ORGANIC CHEMICALS; SEWAGE; WASTE DISPOSAL, FLUID;

EID: 84868289126     PISSN: 15513793     EISSN: None     Source Type: Journal    
DOI: 10.1002/ieam.1274     Document Type: Article

References (63)

1. Anderson PD, D'Aco VJ, Shanahan P, Chapra SC, Buzby ME, Cunningham VL, DuPlessie BM, Hayes EP, Mastrocco FJ, Parke NJ. 2004. Screening analysis of human pharmaceutical compounds in U.S. surface waters. Environ Sci Technol 38:838-849.
2. Anderson PO, Knoben J, Troutman W. 2002. Handbook of clinical drug data. 10th ed. New York: McGraw-Hill. 1148 p.
3. Barr WH, Gerbracht LM, Letcher K, Plaut M, Strahl N. 1972. Assessment of the biologic availability of tetracycline products in man. Clin Pharmacol Ther 13:97-108.
4. Belfroid AC, Van der Horst A, Vethaal AD, Schafer AJ, Rijs GBJ, Wegener J, Cofino WP. 1999. Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in the Netherlands. Sci Total Environ 225:101-108.
5. Bock M, Lyndall J, Barber T, Fuchsman P, Perruchon E, Capdeville M. 2010. Probabilistic application of a fugacity model to predict triclosan fate during wastewater treatment. Integr Environ Assess Manag 6:393-404.
6. Burrows GE. 1980. Pharmacotherapeutics of macrolides, lincomycins, and spectinomycin. J Am Vet Med Assoc 176:1072-1077.
7. Caldwell DJ, Mastrocco F, Nowak E, Johnston J, Yekel H, Pfeiffer D, Hoyt M, DuPlessie BM, Anderson PD. 2010. An assessment of potential exposure and risk from estrogens in drinking water. Environ Health Perspect 118: 338-344.
8. Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, Zuccato E. 2006. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 40:357-363.
9. Cha J, Cupples AM. 2009. Detection of the antimicrobials triclocarban and triclosan in agricultural soils following land application of municipal biosolids. Water Res 43:2522-2530.
10. Choi K, Kim Y, Park J, Park CK, Kim M, Kim HS, Kim P. 2008. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci Total Environ 405:120-128.
11. Clarke BB, Smith SR. 2011. Review of emerging organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ Int 37:226-247.
12. Cunningham VL. 2008. Environmental exposure modeling: application of PhATETM and GREAT-ER to human pharmaceuticals in the environment.
13. In: Kuemmerer K, editor. Pharmaceuticals in the environment: sources, fate, effects and risks. Berlin, Heidelberg: Springer-Verlag.
14. Cunningham VL, Binks SP, Olson MJ. 2009. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul Toxicol Pharmacol 53:39-45.
15. Cunningham VL, Perino C, D'Aco VJ, Hartmann A, Bechter R. 2010. Human health risk assessment of carbamazepine in surface waters of North America and Europe. Regul Toxicol Pharmacol 56:343-351.
16. Desbrow C, Routledge EJ, Brighty GC, Sumpter JP, Waldock M. 1998. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32:1549-1558.
17. Federle TW, Kaiser SK, Nuck BA. 2002. Fate and effects of triclosan in activated sludge. Environ Toxicol Chem 21:1330-1337.
18. Feijtel TCJ, Matthijs E, Rottiers A, Rijs GBJ, Kiewiet A, de Nijs A. 1995. AIS/CESIO environmental surfactant monitoring programme. Part I: LAS monitoring study in "de Meer" STP and receiving river "Leidsche Rijn." Chemosphere 30:1053-1066.
19. Gobel A, McArdell CS, Joss A, Siegrist H, Giger W. 2007. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci Total Environ 372:361-371.
20. Golet EM, Xifra I, Siegrist H, Alder AC, Giger W. 2003. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ Sci Technol 37:3243-3249.
21. Griffith RS, Black HR. 1970. Erythromycin. Med Clin North Am 54:1199-1215.
22. Gulkowska A, Leung HW, So MK, Taniyasu S, Yamashita N, Yeung LWY, Richardson BJ, Lei AP, Giesy JP, Lam PKS. 2008. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water Res 42:395-403.
23. Hannah RE, D'Aco VJ, Anderson PD, Buzby ME, Caldwell DJ, Cunningham VL, Ericson JF, Johnson AC, Parke NJ, Samuelian JH, Sumpter JP. 2009. Exposure assessment of 17a-ethinylestradiol in surface waters of the United States and Europe. Environ Toxicol Chem 28:2725-2732.
24. [HERA] Human and Environmental Risk Assessment. 2009. Human and environmental risk assessment on ingredients of European household cleaning products. LAS Linear Alkylbenzene Sulphonate. Version 4. Available from: http://www.heraproject.com/RiskAssessment.cfm?SUBID=48, 2009.
25. Higgins CP, Sharp JO, Sepulvado JG, Littrell B, O'Connor G, Snyder EM, McAvoy DC. 2010 Trace organic chemicals in biosolids-amended soils, state-of-the-science review. WERF Report SRSK5T09. Alexandria, VA: Water Environment Research Foundation.
26. IMS Health. 2009. IMS Midas Quantum July 2008-August 2009. Collegeville, PA: IMS Health.
27. Jacobsen BN, Kjersgaard D, Winther-Nielsen M, Gustavson K. 2004. Combined chemical analyses and biomonitoring at Avedoere wastewater treatment plant in 2002. Water Sci Technol 50:37-43.
28. Jaffe JM, Colaizzi RI, McDonald RH. 1973. Effect of altered urinary pH on tetracycline and doxycycline excretion in humans. J Pharmacokinet Biopharm 1:267-282.
29. Joss A, Keller E, Alder AC, Gobel A, McArdell CS, Ternes TA, Siegrist H. 2005. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39:3139-3152.
30. Joss A, Zabczynski S, Gobel A, Hoffmann B, Loffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H. 2006. Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Res 40:1686-1696.
31. Kinney CA, Furlong Et, Zaugg SD, Burkhardt MR, Werner SL, Cahill JD, Jorgensen GR. 2006. Survey of organic wastewater contaminants in biosolids destined for land application. Environ Sci Technol 40:7207-7215.
32. Lindberg RH, Olofsson U, Rendahl P, Johansson MI, Tysklind M, Andersen BAV. 2006 Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge. Environ Sci Technol 40:1042-1048.
33. Lozano N, Rice CP, Ramirez M, Torrents A. 2010. Fate of triclosan in agricultural soils after biosolid applications. Chemosphere 78:760-766.
34. McAvoy DC, Eckhoff WS, Rapaport RA. 1993. Fate of linear alkylbenzene sulfonate in the environment. Environ Toxicol Chem 12:977-987.
35. McAvoy DC, Schatowitz B, Jacob M, Hauk A, Eckhoff WS. 2002. Measurement of triclosan in wastewater systems. Environ Toxicol Chem 21:1323-1329.
36. Metcalf and Eddy. 1979. Wastewater engineering: Treatment disposal reuse. New York (NY): McGraw-Hill. 414 p.
37. Meyer MC, Dann RE, Whyatt PL, Slywka GWA. 1974. The bioavailability of sixteen tetracycline products. J Pharmacokinet Pharmacodynam 2:287-297.
38. Mogensen AS, Haagensen F, Ahring BK. 2003. Anaerobic degradation of LAS. Environ Toxicol Chem 22:706-711.
39. Norwegian Scientific Committee for Food Safety (VKM). 2009. Risk Assessment of contaminants in sewage sludge applied on Norwegian Soils. Opinion from the panel on contaminants. Oslo, Norway: VKM. Docnr. 05/511.
40. Oreskes N, Shrader-Frechette K, Belitz K. 1994. Verification, validation and confirmation of numerical models in the earth sciences. Science 263:641-646.
41. Page RL, Ruscin JM, Fish D, Lapointe M. 2001. Possible interaction between intravenous azithromycin and oral cyclosporine. Pharmacotherapy 21:1436-1443.
42. Paxéus NA. 2004. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, b-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 50:253-260.
43. Pfizer. 2009. Pfizer Zmax1 prescribing information. New York (NY): Pfizer. LAB- 0384-3. 0, 2009.
44. [PDR] Physicians' Desk Reference. 2004. Product Information. 58th ed. Montvale (NJ): Thomson PDR.
45. Radjenovic J, Petrovic M, Barcelo D. 2009. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43:831-841.
46. Robinson PF, Liu Q-TL, Riddle AM, Murray-Smith R. 2007. Modelling the impact of direct phototransformation on predicted environmental concentrations (PECs) of propranolol hydrochloride in UK and US rivers. Chemosphere 66:757-766.
47. Scheurer M, Sacher F, Brauch H-J. 2009. Occurrence of the antidiabetic drug metformin in sewage and surface waters in German. J Environ Monitoring 11:1608-1613.
48. Schwab BW, Hayes EP, Fiori JM, Mastrocco FJ, Roden NM, Cragin D, Meyerhoff RD, D'Aco VJ, Anderson PD. 2005. Human pharmaceuticals in U.S. surface water: A human health risk assessment. Regul Toxicol Pharmacol 42:296-312.
49. Smith SR. 2009. Organic contaminants in sewage sludge (biosolids) and their significance for agricultural recycling. Philos Trans R Soc Ser A Math Phys Eng Sci 367:4005-4010.
50. Struijs F. 1996. SimpleTreat 3.0: A model to predict the distribution and elimination of chemicals by sewage treatment plants. National Institute of Public Health and Environmental Protection Report 719101025. Biltoven, The Netherlands: National Institute of Public Health and Environmental Protection.
51. Struijs F, et al. 1991. SimpleTreat: A spreadsheet-based box model to predict the fate of xenobiotics in a municipal waste water treatment plant. National Institute of Public Health and Environmental Protection Report 670208002. Biltoven, The Netherlands: National Institute of Public Health and Environmental Protection.
52. Stumpf M, Ternes T, Wilken R-D, Rodrigues SC, Baumann W. 1999. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135-141.
53. Tchobanolous G, Burton F. 1991. Wastewater engineering treatment, disposal and reuse. 3rd ed. Boston (MA): Metcalf and Eddy.
54. Terzic S, Senta I, Ahel M, Gros M, Petrovic M, Barcelo D, Muller J, Knepper T, Marti I, Ventura F, Jovancic P, Jabucar D. 2008. Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. Sci Total Environ 399:66-77.
55. Trautwein C, Kummerer K. 2009. Incomplete degradation of the type II antidiabetic Metformin, University Medical Center Freiburg. Available from: http:// www.epilepsiezentrum.uniklinik-freiburg.de/iuk/live/umweltforschung/ veroeffentlichungen/Poster_Metformin_Knappe.pdf, Accessed 3/21/10.
56. Tuomisto J, Mannisto P. 1973. Cross-over study of ten tetracycline preparations. Eur J Clin Pharmacol 6:64-68.
57. [USEPA] US Environmental Protection Agency. 2003. Control of pathogens and vector attraction in sewage sludge (including domestic septage) under 40 CFR Part 503. Cincinnati, OH: USEPA. EPA/625/R-92/013.
58. [USEPA] US Environmental Protection Agency. 2009. Targeted national sewage sludge survey sampling and analysis technical report. Washington, DC: USEPA. EPA-822-R-08-016.
59. [USEPA] US Environmental Protection Agency. 2008. Clean Watersheds Needs Survey 2008 Report to Congress. Washington, DC: USEPA. EPA-832-R-10-002.
60. Vasskog T, Anderssen T, Pedersen-Bjergaard S, Kallenborn R, Jensen E. 2008. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J Chromatogr 1185:194-205.
61. Walters E, McClellan K, Halden RU. 2010. Occurrence and loss over 3 years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms. Water Res 44:6011-6020.
62. Xia K, Hundal LS, Kumar K, Armbrust K, Cox AE, Granato TC. 2010. Tricarban, triclosan, polybrominated diphenyl ethers, and 4-nonylphenol in biosolids and in soil receiving 33-year biosolids application. Environ Toxicol Chem 29:597-605.
63. Yasojima M, Nakada N, Komori K, Suzuki Y, Tanaka H. 2006. Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water Sci Technol 53:227-233.